CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Delaware Bill Would Allow Medical Cannabis Operators To Sell Adult-Use Cannabis

In Delaware, a new bill is being proposed to allow medical cannabis businesses to also sell adult-use cannabis once the state’s adult-use sales begin. House Bill 408 was recently introduced on May 16 by sponsors Rep. Ed Osienski and Sen. Trey Paradee. Delaware’s Marijuana Control Act was enacted on April 27, 2023 without the signature of Gov. John Carney, and went into effect starting on August 1, 2023. It created four different license types but none of which currently permit medical cannabis compassion centers to take part in the upcoming launch of adult-use sales. If passed, HB-408 would create a temporary conversion license that medical cannabis businesses can apply for in order to sell adult-use cannabis, and if the application is approved, the license would expire after four years have passed, and can then be renewed again. “As Delaware moves closer to the launch of recreational marijuana sales, it’s important that we continue exploring and implementing policies that will bolster the program’s success and support both new and existing retailers,” Osienski said in a press release. “Our experienced compassion centers are well-equipped to navigate this transition, and the funds generated from their conversion license fees will serve as a vital funding source for social equity applicants, empowering them to kickstart their ventures.” According to HB-408, the medical cannabis business must currently be eligible for renewal within the medical program, must be able to show that it can meet market demands (in addition to verify its plans for continued service in medical cannabis and show support for the social equity program), and have a signed labor peace agreement with a labor organization. Applicants must also pay the fee for a conversion license, which is currently set at $100,000 per license. The proceeds from the fee will be used to give financial assistance to conditional license holders who are also social equity applicants. “For us, passing the Marijuana Control Act was always about our desire to replace an illegal market that has overwhelmed our court system and damaged lives with a legal, regulated and responsible industry that will create thousands of good-paying jobs in Delaware,” Paradee said. “We also need to protect the jobs created by our compassion centers, who have already put in the hard work of standing up an industry and have the capacity and infrastructure to meet demand on Day 1.” Paradee added that providing an avenue for medical cannabis businesses to participate in the adult-use market will aid communities harmed by the War on Drugs. If HB-408 became law, it would require that the Delaware Office of the Marijuana Commissioner open up applications between August 1-November 1, 2024. For now, it heads to the House Economic Development/Banking/Insurance and Commerce Committee. Earlier this year, Osienski introduced another bill, House Bill 285, which aims to expand the Delaware medical cannabis program. Medical cannabis was first legalized in Delaware in 2011 but sales didn’t begin until 2015 when the first dispensary began operation. If passed, HB-285 would allow senior citizens to become medical cannabis patients, permit healthcare providers to determine whether or not medical cannabis could be useful for a patient, and improve the cannabis registry ID card process. “With the full legalization of adult-use recreational marijuana last year, my colleagues and I agreed that our medical marijuana law needed to be updated to help the people who rely on those products get the therapy they need,” said Sen. Kyra Hoffner, according to WBOC. “These changes will allow healthcare providers to make sound decisions about which treatments best fit their patients, and make those treatments more readily accessible to people who need them the most. I want to thank my colleagues in the General Assembly for continuing to support a responsible and reasoned approach to both recreational and medical marijuana in the First State.” HB-285 is currently waiting on Gov. Carney’s desk for a signature or veto. In April, Osienski and Paradee, in addition to state treasurer Colleen Davis, filed House Bill 355, which would implement state protections for banks who seek to serve licensed cannabis businesses.  This would apply to banks as well as “credit unions, armored car services, and providers of accounting services” which wouldn’t be subject to prosecution under Delaware state law. “This is really a public safety issue,” said Paradee last month. “We do not want any of the current medical cannabis providers or the coming recreational cannabis providers to struggle with that issue.” While these bills await their respective approvals, many eagerly await the news of when adult-use cannabis sales will begin. While an official date has not yet been verified, the most recent launch estimate is currently looking toward March 2025, according to Delaware Marijuana Commissioner Robert Coupe told the Joint Finance Committee in February. In the meantime, a slew of other bills recently headed to Gov. Carney’s desk for approval, such as House Substitute 1 for House Bill 162, which would legalize human composting. If approved, it would allow licensed morticians to care for the deceased as they decompose by mixing the bodies with wood chips, straw, and other organic materials. After fully decomposed (estimated to take approximately 30 days), the compost would be returned to the family to use as they see fit.

https://hightimes.com/

Iowa Governor Signs Bill To Regulate Hemp Products

On May 17, Iowa Gov. Kim Reynolds signed 20 bills prior to the end of the legislative session. One of which was House File 2605, which establishes regulations regarding hemp-derived consumable products that contain THC. The passage of HF-2605 includes new restrictions and penalties applied for hemp-derived consumable sales, manufacturing, and possession. Now, such products may only contain 4 mg of THC per serving, or 10 mg THC per container on a dry weight basis, according to the Iowa Capital Dispatch. It also requires that warning labels be adhered to those products, which can be sold to adults over 21, and prohibits the use of synthetic THC. Many people reached out expressing their opposition to the bill, and called for Reynolds to reject it. Prior to signing HF-2605, Reynolds explained that she considered both sides of the argument for and against the bill. “I have concerns about this bill and have heard from individuals and groups on both sides of the issue,” said Reynolds. “Ultimately, I am signing it into law to protect minors from dangerous and intoxicating products. At the same time, we’ve taken steps to ensure that children who are resistant to medications and suffer from seizures and other medical conditions continue to have access to consumable hemp alternatives for relief.” In early April, HF-2605’s floor manager, Sen. Dan Dawson, explained that the bill is a necessary update to the Iowa Hemp Act. “The medical cannabidiol program actually puts an individual with a doctor to get these products, that’s the biggest distinction,” Dawson said. “The Iowa hemp program has none of those barriers there. So if we want to protect Iowans with these products… there has to be some type of guardrails on here, to make sure that the medical cannabidiol program is the program that we can direct Iowans to when they have one of these diagnosed conditions.” In March, Rep. John Forbes expressed concern for the possible “unintended consequences” for patients who rely on hemp-based medicine that’s not included in the state medical cannabis program. “I think we’re not hitting the nail on the head here, when it comes to being able to help Iowans that are seeking out this as an alternative to maybe taking other prescription medications, and increasing quality of life, helping them,” Forbes said at the time. During that same meeting, Sen. Tom Shipley, who helped create the Iowa Hemp Act when it passed in 2019, said he saw opportunities for loopholes. However, he was more than happy to support HF-2605 as a way to improve upon the current act. “We found out some people could find an angle to get around things and do things that are not good for Iowans,” said Shipley. “And I just want to stand up in support of Senator Dawson’s bill to try and close some of these loopholes that even I could figure out were coming.” Following Gov. Reynolds’ approval, many others welcomed the new regulations. “This has created a lot of awareness about these products, and it’s put things in place that were necessary,” said Alec Travis, owner of the Iowa-based brewery Field Day Brewing, which offers THC-infused beverages. “Having a small cap while people get used to these products is probably good.” Earlier in February, House Study Bill 665 was introduced, which would give the Iowa Department of Health and Human Services the ability to regulate consumable hemp products. “We thought we were dealing with the intoxicating aspect, only to find out that there are ways to get around that,” said Rep. Steve Holt. “So it’s sort of the wild, wild west out there in a lot of ways, with THC-infused drinks being able to be served to minors, a lot of other things going on that are not acceptable.” The bill has not received any further hearings after February 19.  Similar hemp regulations are also being pursued by other states, such as Georgia. Earlier this month, Gov. Brian Kemp signed Senate Bill 494, which “makes changes to the framework for hemp regulation in Georgia to allow the Georgia Department of Agriculture to have greater oversight and enforcement power and adds labeling, packaging, and marketing requirements to protect children from misleading and dangerous marketing.”  At the signing ceremony, Kemp explained that hemp cultivation is rapidly growing. “The vast majority of the jobs and the vast majority of the investment that have been created by these great private-sector companies … have been located outside the metro-Atlanta counties, creating opportunities for Georgians to succeed no matter what their zip code,” Kemp said. Additionally, Kemp signed Senate Bill 420 as well, which prevents a “foreign adversary” from owning agricultural land. “As valued members of our state’s number one industry, Georgia’s farming families deserve our enduring support as they face unprecedented challenges, including having to navigate disastrous federal energy policies, attempts by foreign adversaries to acquire farm land, and theft of property,” Kemp said. “We are tackling these challenges head on, and I want to thank our legislative partners for their work on these important issues.” On May 17, GOP House representatives recently published a 942-page draft version of the 2024 Farm Bill. Although still a work in progress, the draft currently includes a revision of the word “hemp” and provides numerous separate categories to label cultivators growing hemp for the purposes of animal feed, fiber, or non-food-based production of grain, seed, or oil.

https://hightimes.com/

Research Shows Evidence of Methylphenidate Provoking Relapse in Former Cocaine Users

In a study that was originally published late last year, researchers unveiled the risks for former cocaine users who may relapse by taking methylphenidate. Methylphenidate is used as a treatment for attention-deficit hyperactivity disorder (ADHD), and is often recognized through brands such as Aptensio XR, Concerta/Concerta XR-ODT, Jornay PM, and most commonly, Ritalin. As a stimulant drug, these medicines increase brain neurotransmitters such as dopamine and norepinephrine, to help a patient achieve better focus and behavior control. To a lesser degree, methylphenidate can also be used to treat narcolepsy as well. Methylphenidate is currently a Schedule III substance in the U.S., and has a history of misuse. According to Psypost.org, college students sometimes use methylphenidate to help them focus. Although methylphenidate has shown some promise in studies as a treatment to help people abusing cocaine, it comes with a few concerning side effects such as cravings and relapse. Researchers also found that methylphenidate use in conjunction with fluoxetine (a treatment for depression) actually mirrors the effects of cocaine. The study entitled “Methylphenidate with or without fluoxetine triggers reinstatement of cocaine seeking behavior in rats,” was originally published in the December 2023 issue of Neuropsychopharmacology, and lead by researchers Lorissa Lamoureux, Joel Beverly, Heinz Steiner, and Michela Marinelli. Study author Michela “Micky” Marinelli works at the University of Texas as an associate professor, and explained the history behind this unique study topic. “The interest started many years ago, from a creative graduate student I worked with in Dr. Frank White’s lab: Cindy Brandon. Cindy had school-aged children and noticed that more and more children at school were being diagnosed with ADHD and treated with methylphenidate,” Marinelli explained. “She wondered if this could pose a risk to develop stimulant addiction and she set out to study this in rodent models. She found that rats are not likely to self-administer very low doses of cocaine (they are too low to have an effect) but they will self-administer these low doses of cocaine if they have been previously exposed to methylphenidate (Brandon et al., 2001). She continued this line of research as a postdoctoral fellow in Dr. Heinz Steiner’s lab. Dr. Steiner was an expert in studying gene expression and together they found that methylphenidate alters gene expression in the brain in ways that were similar to cocaine, but not quite the same.” She added that according to Dr. Steiner’s research, methylphenidate elevates just dopamine and norepinephrine in the brain, but cocaine elevates those two as well as serotonin. Because of these similarities. “So he asked: what would happen if people taking methylphenidate also take antidepressant drugs like selective serotonin-reuptake inhibitors (SSRIs), which elevate serotonin. Would the methylphenidate + SSRI combination become cocaine-like?” Dr. Steiner observed gene expressions in the brain, which revealed the answer to his questions. Together, Dr. Stein and Marinelli wrote a grant study revealing the risks of using both a methylphenidate and an SSRI. “At this point in time, methylphenidate started to be taken not just in the clinic, as a medication for ADHD but also recreationally or as a ‘cognitive enhancer’ so we set out to examine both low and high doses of methylphenidate, to mimic (as much as possible in a rat) doses used in the clinic (low doses) vs. those used recreationally or as a cognitive enhancer (high doses),” Marinelli explained. In the most recent study, researchers studied male Sprague Dawley rats in a controlled setting. Rats were trained to self-administer cocaine as a way to mimic youth cocaine use. This was followed by a withdrawal phase when cocaine access was removed, where rats exhibited “cocaine-seeking behavior,” which included “nose poking” whenever they would receive the cocaine. Then an extinction phase followed, where the rats would learn to no longer exhibit that behavior. The next step included giving the rats either a high dose of methylphenidate or a combined dose of methylphenidate and fluoxetine to see if the rats would relapse and begin exhibiting cocaine-seeking behavior once again. “One needs caution extrapolating studies in rodents to human,” Marinelli said to PsyPost in an interview. “But at least in rats, if one has previously taken cocaine, taking methylphenidate can push that individual (rat) to seek cocaine again. This happens at high doses of methylphenidate, comparable to those used recreationally or as a cognitive enhancer.” Researchers also observed that there was no significant difference between rats who took methylphenidate alone, or the combined methylphenidate with fluoxetine, showing that fluoxetine doesn’t impact the effect. “We were surprised that adding a SSRI (fluoxetine) to methylphenidate did not exacerbate the effects of methylphenidate,” said Marinelli. “The effects we saw were due to methylphenidate alone.” It’s easier to study rats in an isolated, controlled environment versus studying humans, which leaves much to be desired in human observations. “It will be important to examine how much this work translates to human populations,” said Marinelli. “These are difficult to study as, unlike rats, they are not in a controlled environment, where we can determine the dose, duration, and manner in which they are exposed to different drugs or medications or treatments.” The rats also did not have ADHD, which could lead to different results in a human trial. “When I teach about addiction in summer camps or to undergraduate students, I ask how many of them know of someone who has taken methylphenidate as a cognitive enhancer. Almost all raise their hand. When I then ask them if any of them have, nobody raises their hand—so self-reported use of methylphenidate might be difficult to obtain. Anonymous questionnaires are helpful, but not if one wants to obtain more information from a person, which is only done face-to-face.”

https://hightimes.com/

Fentanyl Dealer on Snapchat Who Caused Deadly Overdoses Gets 20 Years in Federal Prison

A man who used Snapchat to sell fake oxycodone pills that actually contained fentanyl—leading to the death of a teenage girl as well as several other overdoses—faces 20 years in prison. Jeremial Lee Leach, 20, of Evansville, Indiana, has been sentenced to 20 years in federal prison, followed by five years of supervised release, after pleading guilty to one count of Distribution of Fentanyl Resulting in Death, one count of distribution of fentanyl, and one count of distribution of fentanyl resulting in serious bodily injury. Michael Gannon, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Indianapolis, and U.S. Attorney Zachary A. Myers for the Southern District of Indiana released an announcement on May 17 describing the ordeal and the consequences. Leach sold fentanyl on Snapchat as “Mel,” resulting in at least three overdoses, one of which resulted in the death of a 19-year-old woman. “Mel” sold small blue pills marked with M 30 which is supposed to indicate they contain oxycodone hydrochloride—i.e. sold as Oxycontin, Reltebon, Zomestine, etc. Researchers call fake M 30 pills as “Dirty 30s,” and they’re highly dangerous—the slightest miscalculation of fentanyl can easily stop breathing. “This young woman should be alive today. Mr. Leach pushed deadly poison over social media, ending a teenager’s life far too early, and risking many more,” said U.S. Attorney Myers. “Fentanyl traffickers commit their crimes with utter disregard for the lives of our friends and neighbors or the harm they cause to families in our community. I commend the outstanding work of the DEA, the Evansville Police Department, the Evansville-Vanderburgh County Drug Task Force, and our federal prosecutors to secure some measure of justice for the victims of this fentanyl dealer. The sentence imposed here should serve as a warning: these poisons kill—and selling them will earn you decades in federal prison.” On June 25, 2022, in the late hours of the night, officers with the Evansville Police Department (EPD) responded to a call about an overdose from a residence on Wedeking Avenue. The first woman was lucky—and responders were able to revive her with naloxone.  But within hours, at approximately 10:55 a.m. the next morning, EPD officers responded to the same residence for the overdose of another woman, who was only 19 years old, who subsequently died. The coroner found a fake oxycodone pill containing fentanyl when examining the body. The cause of both overdoses was determined to be fentanyl intoxication. But “Mel” on Snapchat wasn’t done dealing his fake oxycodone pills. On Aug. 20, 2022, EPD officers were dispatched to a restaurant located on Hirschland Road concerning an overdose. There, the officers found a woman hunched over, falling out of consciousness. But she was also lucky and was revived with naloxone and the woman regained consciousness. The woman told police that she thought she had simply taken a 30 mg tablet of oxycodone, which would not have caused an overdose. The woman’s companion, identified as “Leach,” supplied the pill at a residence on Shanklin Avenue. It was again traced to “Mel” after officers with the Evansville-Vanderburgh County Drug Task Force set up two more drug deals a few months later. Police then executed a search warrant at Leach’s residence on Shanklin Avenue, where officers found 33 blue pills marked “30,” a digital scale, two 9mm pistols, and approximately $1,843 in cash. “The sentence imposed on Mr. Leach is righteous and justified. Mr. Leach utilized social media platforms to advertise the sale of fentanyl and continued distributing the poisonous fentanyl even though it had already caused fatal and near fatal overdoses. The DEA would like to extend their deepest condolences to the Duncan family and all families who have lost a loved one to a fentanyl poising,” said DEA ASAC Gannon. “DEA remains committed to working hand in hand with our state, local and federal partners in order to keep our communities safe.  DEA commends the outstanding work by the Evansville Police Department, The Evansville-Vanderburgh County Drug Task Force and the United States Attorney’s Office.” A much lesser “threat” on Snapchat is the sale of weed. A woman was busted in 2018 for setting up her weed business on Snapchat (which is admittedly much safer than selling fentanyl.) The Beatrice Daily Sun reported in 2018 that Nebraska authorities were tipped off about a Snapchat video made by a woman named Madison D. Carlson. In the video, she held a large bag of cannabis, with a corresponding caption reading “Hit me up.” Following the post, someone snitched, and authorities went to Carlson’s residence around 9:30 p.m. and immediately noticed two cars in a nearby alley with their lights on. In one vehicle, police found Carson with one female minor. According to police documents, the car reeked of weed. In the other, a male juvenile, who, upon further inspection, was carrying a concealed bag of marijuana in his waistband. The two female accomplices told police they had just gotten rid of the pot until Carlson was removed from the vehicle, and eventually forked over an additional 32 grams and $80 in cash. Since minors were involved, Carlson also faced serious charges, even though cannabis is not capable of causing bodily injury in the same way that fentanyl is. Plugs can be found on just about any social media platform, but especially when it comes to pills, buyer beware, as deadly counterfeit pills abound.

https://hightimes.com/

Study: Cannabis Use Associated with ‘Marginal Increase’ in Light Physical Activity

As modern-day cannabis research persists, studies have increasingly shed light on prevailing stereotypes of cannabis users, those persistent attitudes that cannabis makes people lazy and unmotivated.  Given the increased accessibility of cannabis in the United States and beyond, it’s now clear that there is no fixed demographic when it comes to cannabis use. The research shows it, too, regularly concluding that cannabis may actually fit in nicely with those pursuing a more active lifestyle. One of the most recent studies to examine this relationship was published last week in the journal Cannabis and Cannabinoid Research, measuring the physical activity and sedentary behavior among young-to-midlife adults and confirming that cannabis use is actually associated with a marginal increase in daily light physical activity (LPA). Researchers used data from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2014 to investigate the relationship between cannabis and physical activity.  The study included U.S. adults aged 18 to 59 who responded to the questionnaire and had at least four days of activity data using wrist-worn accelerometers to track physical activity. The findings drew data from 4,666 adults, 658 (14.1%) of which reported cannabis use within the past 30 days. Researchers said that it is “the largest cohort in which the relationship between cannabis use and physical activity has been studied.” The accelerometer data found few differences in sleep or physical activity between people who did and did not use cannabis over the past month. While there were also no differences found between groups in daily moderate-to-vigorous physical activity (MVPA) time, daily time spent doing LPA was higher among recent cannabis users. However, the difference is minimal, as those who used cannabis in the past month had 102 minutes of light physical activity per day versus 99 minutes for those without past-month cannabis use. “With the rising prevalence of cannabis use, there have been concerns of its potential effects on physical activity levels,” the study concludes. “In this population level-analysis, recent cannabis use was not independently associated with daily sedentary time or MVPA, and it was associated with a marginally greater daily LPA time of unclear clinical significance.” Researchers noted that more than half of the participants were 18-29 years old, “which may suggest selection bias toward younger and healthier people in the NHANES sample” and may not be a representative sample of the general adult population.  The study also did not explore motivations surrounding cannabis use, though researchers noted the reasons could include exercise, pain, anxiety or sleep. The study also did not include data surrounding frequency of consumption or specific products used. Authors said that further reason could be useful to examine whether the findings were generalizable to specific subgroups who use cannabis for chronic or neuropathic pain. “Our findings provide evidence against existing concerns that cannabis use independently promotes sedentary behavior and decreases physical activity,” authors concluded, highlighting that the longstanding “lazy stoner” archetype often portrayed with chronic cannabis users “does not acknowledge the diverse uses of cannabis today.” It’s one of several recent students examining cannabis use and physical activity, similarly showing that these tired attitudes surrounding cannabis consumers may need to be examined in a new way in regard to today’s modern cannabis community and broad user base. A study published last month found that regular cannabis consumption was associated with more positive emotions and fewer negative emotions, alongside minimal effects of motivation or objective effort willingness. “When frequent cannabis users get high, in other words, they are no more apathetic, nor less extrinsically or intrinsically motivated to pursue their goals,” researchers said. “They are, however, slightly less motivated to do things when they are high because they would be upset with themselves if they did not do them.” Other research has honed in on cannabis use and physical activity specifically.  Another study from earlier this year showed that cannabis users take more walks on average compared to non-users and e-cigarette users and that they are no less likely to engage in basic exercise and strength training compared to non-users.  A similar study looking specifically at Americans 60 and older found that this demographic of cannabis consumers exercise more than their non-cannabis-consuming counterparts, while another study found that cannabis is increasingly being used in conjunction with exercise and may increase positive mood and enjoyment during workouts.

https://hightimes.com/

High Five: 5 Cultivation Styles

Using aeroponics, cannabis roots are suspended in the air and are fed water and nutrients via a fine mist. Aeroponics doesn’t require any type of medium or substrate, and the growing style is commonly used to develop clones. This is done through the use of cloners, or mini aeroponic systems that blow a mist over clones to allow growth. The lack of a medium usually ends up meaning less space per plant, and the roots don’t have to fight for space. One of the cons to aeroponic growing is that when the pumps break down, the roots die quickly without an alarm and a fast response. Since growers are dependent on timers, valves, and pumps working properly, there are plenty of ways to mess up the system if you don’t know what you’re doing. This relatively rare method combines aquaculture—small fish, crayfish, prawns, or snails—with hydroponics, feeding the plants with natural nutrients produced by aquatic animals instead of synthetic nutrients. The main reason growers experiment with aquaponics is for sustainability and eco-friendly purposes. It abandons any reliance on fertilizers that are mined and manufactured, so you can be sure no synthetic fertilizers end up in the final, chemical-free product. Online, some people say aquaponics is a complicated, overhyped process with few rewards, while others praise the benefits. Hydroponic cultivation is the process of growing plants in a water-based nutrient solution that doesn’t use soil. Roots are grown in substrates like vermiculite or perlite (porous minerals), as well as coco coir (coconut husk fiber). They absorb water and nutrients like a sponge and roots grow around them. Hydroponics ideally provides a more controlled grow site, promoting faster growth, potentially higher yields, and higher nutrient uptake. Growers often take drastic measures to ensure their hydro setup is sterile, and they have to deal with pesticides less often.  The Sea of Green (SOG) growing technique is designed to maximize the yield per square foot of a grow operation by growing lots of small cannabis plants rather than fewer larger ones. It creates a dense canopy that can be harvested earlier with the plants growing a single large bud instead of branching out. A variation, the Screen of Green (SCROG) method, utilizes horizontal netting to create uniformity. SOG and SCROG setups are typically created by commercial operations that deal with larger-scale grows. These ways can be maximized through super cropping and other pruning and suspension techniques. Keep it natural, the way nature intended, by growing plants in soil. Generally speaking, it’s easier to maintain a plant grown in soil than in most growing methods and it’s a great medium for beginners. Soil is also an abundant source found everywhere, while quality varies. Living soil, a variation of this technique, is when the soil contains organic matter, minerals, water, air, and microorganisms that work together synergistically. Cultivating in living soil is believed to maximize the terpene and flavor profiles of plants. This article was originally published in the April 2024 issue of High Times Magazine.

https://hightimes.com/

Marital Status Uniquely Affects Psychedelic Experiences, Study Shows

As it turns out, your marital status could affect the extent to which psychedelics can lower your stress levels. And it appears that single folk may experience the greatest benefit of psychedelics.  An analysis of data from the National Survey of Drug Use and Health revealed that individuals who had used psychedelics at least once in their lives, in general, had lower levels of psychological distress, according to research PLOS ONE. This association was most pronounced among people who were single and significantly weaker among those who were married, widowed, or divorced, PsyPost reports.  There’s already loads of research that clearly establishes a positive correlation between psychedelics and mental health. The Department of Veteran Affairs is funding research into psilocybin and MDMA to treat PTSD and depression. The FDA recently recognized LSD’s potential to treat anxiety. And there’s a study suggesting that DMT may be an effective treatment for depression. The research into the martial status and tripping looked at classical psychedelics like LSD, psilocybin, mescaline, and DMT, in addition to MDMA.  The study’s author, Sean M. Viña, sought to explore the relationship between psychedelic use, marital status, household size, and psychological distress. He hypothesized that married individuals who have used psychedelics might experience reduced distress and that those in larger households would face increased distress. He also suspected that the beneficial effects of psychedelics on distress would be least pronounced among people with large households.   Viña analyzed data from the National Survey of Drug Use and Health, which is an annual survey conducted across all 50 U.S. states and the District of Columbia. This survey seeks to measure the pervasiveness of substance use and mental health issues in the United States.  This analysis looked at data on people’s distress levels over the past month using the Kessler Psychological Distress Scale. The Kessler Psychological Distress Scale (K10) is a straightforward tool for measuring psychological distress. It consists of 10 questions about emotional states, each with five possible responses. The K10 can be used as an easy screening method to figure out one’s levels of distress (you can try it here).  It also considered whether participants had ever used classic psychedelics like DMT, ayahuasca, psilocybin, LSD, mescaline, peyote, or MDMA. It also included information regarding participants’ marital status, household size, and other demographic details. While single people won in some ways, and we’ll get to that, the results indicated that married individuals experienced lower levels of distress compared to single and divorced people. Married folks’ distress levels were actually comparable to widowed individuals.  Interestingly, the divorced individuals had the highest levels of drug use, unrelated to the psychedelics, which included cannabis but also tobacco, cocaine, tranquilizers, inhalants, pain relievers, and heroin. They also were more likely to have started drinking at an earlier age. While some of that substance use could be in reaction to divorce, it also may indicate that, unsurprisingly, an unhealthy relationship with drugs could lead to relationship problems.  Those who reported using classic psychedelics, in general, had generally less psychological distress. This was held true even after considering marital status and household size. But the connection between psychedelic use and reduced distress was strongest in single individuals. It was also significantly weaker in those who were married, widowed, or divorced. So, while being partnered or mourning a partner could lead to less stress in general, such folks may have a reduced benefit from taking psychedelics.  Notably, and giving child-free people a reason to celebrate, those with the most stress had larger households. If a person using classic psychedelics was married, the connection between living in a large household and experiencing psychological distress was even stronger.  “The results confirm the predictions that LCPU [lifetime classic psychedelic use] exacerbates the negative consequences of household size for the heads of households who are married, widowed, and divorced. The results also suggest that larger households are associated with harm regardless of marital status, but the negative consequences decrease for single psychedelic users as the household size increases,” Viña explained.  Viña went on to conclude that: “Widowed psychedelic users may experience some benefits from living with more people, but these benefits decrease as the household size becomes too large. In contrast, among married or divorced psychedelic users, the distress caused by household size worsens as the family sizes increase. Finally, for widowed psychedelic users, there is a negative association between household size and distress, but this association decreases at a decreasing rate.” So, while, if you’re windowed, it might not be a bad idea to move in with a friend, don’t move in with an entire family.  “These results can be explained by the increasing responsibilities that heads of households face as their families grow, which are then exacerbated by psychedelic use. On the other hand, single individuals may experience a diffusion of responsibility as their family sizes increase,” Viña said.  It’s important to remember that while studies like this are fascinating, we don’t always know if they’re demonstrating correlation or causation. In other words, while psychedelics could lead to less stress for single people, compared to overworked and exhausted moms and dads, on the other hand, it could just be that single people are more likely to have less stress and have a free weekend to spend tripping. 

https://hightimes.com/

Study: 87% of Festival-Goers Plan To Use Drugs, Cannabis Most Popular Choice

It’s the start of a new festival season, as music lovers far and wide prepare for a summer full of multi-day events featuring some of their favorite artists and DJs, along with plenty of dancing. For many, the festival experience also involves consuming a variety of drugs to amp up the experience. This year’s Drug Safety at Music Festivals study, conducted by research firm Innerbody, sheds additional light on the habits and plans of festival goers this year while also addressing some of the best ways for folks to stay safe should they decide to consume substances at these events. The study uses survey data from 900 people and suggests that about 87% of festival attendees plan to take drugs, a 10% increase from last year’s figure.  The study focuses on a variety of topics surrounding drug use at music festivals, beginning with the most popular substances that festival goers plan to use during the upcoming season.  Alcohol is always the top substance consumed at festivals, but the study did not include it and focused solely on drug usage. That said, cannabis takes the top slot by far, with 65.3% of festival goers who plan to use drugs saying they will consume cannabis. Authors note that the widespread legalization of recreational cannabis across the U.S. may make cannabis a less risky option for attendees.  Cocaine was the second most popular choice (46.5%), followed by psychedelics (26.1%), MDMA (19.4%), ketamine (19.3%), amphetamines (13.7%), opioids (12.1%), benzodiazepines (10.1%), synthetic drugs like bath salts or spice (9.7%), hallucinogens like salvia or peyote (6.1%) and inhalants (6%). Plans to use cocaine are up from last year’s numbers, though there was a 2% drop in the number of people who plan to use opioids — which authors noted as surprising given the continued opioid overdose epidemic though still “encouraging.” The study found that rock, hip-hop and EDM are the genres most likely to have audience members under the influence of drugs, with Wisconsin’s Rock Fest claiming the top slot as the festival with the most anticipated drug use, according to survey participants. The weeklong Burning Man festival held in Nevada’s Black Rock Desert took the second slot, while Coachella was third place for most anticipated drug use. The study also looked at drug concealment, consumption and testing behaviors among those planning to consume for festivals, finding that just 32.6% bring their own drugs with them to the event while the remaining 67.4% buy them at the festival. Last year’s results found that 46% planned to bring their own drugs to the events. Millennials were the most likely generation to buy drugs at the venue rather than purchasing them beforehand. In regard to drug testing, a majority (80.3%) test their drugs before the event or festival, an increase from last year’s approximately 67% figure.  “This increase in testing could be due to more awareness surrounding the U.S. opioid crisis and the public education efforts that have taken place,” authors note. “But while the data is encouraging, it still reflects the reality that 20% of festival goers could be taking potentially dangerous drugs at concerts.” Concealing drugs in backpacks and pockets are the most common choices, and researchers also found that attendees tend to take drugs in one of three places with a fairly balanced distribution: the restroom (29%), within the crowd (31%) or outside the festival gates (33%). Though authors indicate that the broader prevalence of drug testing is encouraging, the study notes that more than half of survey participants said they had experienced health-related issues that warranted medical attention while under the influence of drugs at festivals. The most common complications attendees experienced were heat stroke, a bad trip and dehydration.  The survey also found that drug use tended to lead festival goers to engage in riskier behavior at the events, with 66% of both Gen Z and millennial respondents reporting they had done so while attending festivals under the influence. Engaging in sex with a stranger was one of the most prevalent examples, most prominent among millennials, while one in every four millennials also reported “driving dangerously” after a festival ended. Authors note that abstaining and testing drugs before using them are some of the best harm reduction methods, though surveyed festival goers largely reported self-education about the drugs they were using, the risks and potential side effects as their go-to safety measure. The second-most common strategy was starting with a low dosage, followed by drug testing. “Being aware of your surroundings, remaining close to your friends, keeping hydrated, and familiarizing yourself with the location of medical tents are also easy and practical ways to help stay safe at music festivals,” authors close.

https://hightimes.com/

Adult-Use Cannabis Generates Over $20B in State Tax Revenue

Revenue generated by adult-use cannabis markets in the U.S. is showing its true impact on the economy. According to a report  by the Marijuana Policy Project (MPP) adult-use cannabis markets generated over $20 billion in tax revenue since launching in Colorado and Washington a decade ago. In November 2012, Colorado legalized marijuana for adults over age 21 by passing Amendment 64 to the Colorado Constitution. Washington state followed suit with a ballot initiative during the same month. Legal markets launched shortly after, and data on states that have implemented adult-use cannabis markets has been monitored by the MPP since 2014. “Legalizing cannabis for adults has been a wise investment,” the report reads. “Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Through the first quarter of 2024, states have reported a combined total of more than $20 billion in tax revenue from legal, adult-use cannabis sales. In 2023 alone, legalization states generated more than $4 billion in cannabis tax revenue from adult-use sales, which is the most revenue generated by cannabis sales in a single year. In addition to revenue generated for statewide budgets, cities, and towns have also generated hundreds of thousands of dollars in new revenue from local adult-use cannabis taxes.” The report goes through tax revenue collected in each individual state, noting the state markets that are not yet operational. Washington’s tax rate was among the highest in the nation, at a whopping 37% at retail with a 6.5% sales tax. “Twenty-four states have legalized cannabis possession for adults 21 and older. All but one of them—Virginia—have also legalized, regulated, and taxed cannabis sales. In two legalization states—Delaware and Ohio—sales have not begun yet.” The economic benefits that come from legalizing adult-use cannabis should be one of the movement’s greatest selling points, the report mentions. “It is important to note that the financial impact of legalizing and regulating cannabis for adult use is one of the many benefits of legalization,” the report concludes. “Adult-use cannabis legalization has also displaced the criminal market and freed up law enforcement resources to focus on serious crime. In legalization states, authorities actually know who is selling cannabis, where it is being sold, when, and to whom, because cannabis is produced and sold by legitimate, tax-paying businesses instead of drug cartels and criminals. Hundreds of thousands of individuals have been spared traumatic arrests, possible incarceration, and criminal records that shut the door of opportunity. Meanwhile, teenagers’ cannabis use rates haven’t increased, and voter support has grown.” The full report, “Cannabis Tax Revenue in States that Regulate Cannabis for Adult Use,” is available from MPP.  The data appears to align with tax revenue numbers released by the federal government, released in October 2023. The combined totals reveal that states with reported cannabis excise sales tax numbers totaled out to $5.7 billion since Q3 of 2021. A report published by the U.S. Census Bureau recently shows the progress of cannabis tax revenue numbers for each state. It’s the first report of its kind from the bureau and begins with the Q3 2021. “The Quarterly Summary of State and Local Government Tax Revenue provides quarterly estimates of state and local government tax revenue at a national level, as well as detailed tax revenue data for individual states,” the report explains. “The information contained in this survey is the most current information available on a nationwide basis for government tax collections.” It aligns with predictions the MPP released last year, according to a report on May 1, 2023 with data regarding cannabis tax revenue generated by states with legalization. Between 2014 and the end of 2022, the report shows that states had collected over $15.1 billion in tax revenue. Tax revenue from 2022 alone showed more than $3.77 billion collected, which was actually the first year that total state cannabis tax revenues decreased in comparison to 2021 with $3.86 billion. Even with seeing mature cannabis states collecting a decreased amount in cannabis tax revenue and newer states collecting an increased amount, MPP notes that the numbers are influenced by sales comparisons from the pandemic. The 2023 report also includes a year-by-year total of collected tax revenue as well. In 2014, tax revenue reached $68,503,980 and 2018 was the first year that cannabis tax revenue passed the million mark at $1,308,693,928.  MPP’s reports show the true potential that adult-use cannabis can bring, in the form of tax revenue.

https://hightimes.com/

MSO Stocks Soar After Biden Video Confirms Cannabis Is Moving to Schedule III

Cannabis stocks spiked immediately after President Joe Biden announced the reclassification of cannabis from a Schedule I to a Schedule III drug, endorsing the Justice Department’s recommendation.  Biden posted a video on X at 1 p.m. May 16, declaring that the U.S. Department of Justice would indeed reclassify cannabis, and within hours, cannabis-related stocks began rising amid the growing excitement. “Today’s step is another historic step moving forward,” Poseidon Investment Management co-founder Emily Paxhia told Yahoo! Finance on an episode of Market Domination. “I think anything around cannabis reform has been very difficult for the past 10 years plus, obviously, and so anything that’s working through an ordinary process and following the steps as it should is very confirmatory.”  Familiar names of bigger players in the industry are popping up. “We’ve seen increasing volumes in the top names in the industry,” Paxhia added. Multi-state operators (MSOs) would benefit the most from the Schedule III classification, like Canopy Growth, Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis, with operations in about three dozen states that allow cannabis sales. Shares of Canopy Growth, an enormous Canadian cannabis producer that trades on the New York Stock Exchange, rose 15%, to $11.95, after the tweet, Barron’s reports. The reclassification of cannabis doesn’t fix the gap between federal and state law, and it sparked some negative feedback of a potential pharmaceutical takeover. “On behalf of thousands of legal businesses operating across the country, we commend President Biden for taking this important first step toward a more rational marijuana policy,” said Aaron Smith, who heads the National Cannabis Industry Association. “Now it’s time for Congress to enact legislation that would protect our industry.” Forbes reports that shares of Canopy Growth Corp. ended up closing at roughly $11, an increase of over 11% on the day to a one-month high. Canadian cannabis producer Aurora Cannabis’ stock rose nearly 7%, closing Thursday at nearly $8 per share. Cannabis product manufacturer Green Thumb Industries’ stock rose nearly 3%, climbing to a high of just over $13. Shares of Trulieve Cannabis Corp rose as well to nearly 6% to just under $13 per share, while Tilray Brands’ shares increased by roughly 2.5% to just over $2 per share. Shares of Cronos Group also jumped over 4% on Thursday, closing at over $3 per share. It’s important to keep in perspective the overall picture. Despite the recent gains seen by cannabis MSOs, several cannabis-related stocks are far below their 5-year highs. Curaleaf is down nearly 66% from its February 2021 high, while Tilray is down nearly 97% from its high from the same month, Reuters reports. A 60-day commitment period will take place for a space for public input. The Justice Department will take comments on the proposal after it appears in the Federal Register. A final rule would have to be issued before the reclassification would take effect. The process can be lengthy,  and it must undergo a public comment period before it can be implemented, which can take up to a year. Part of the excitement surrounding the reclassification move could be centered on the probate changes in tax policy that is near. Legal advisors are expecting the limitations of tax code Section 280E will change significantly now that cannabis is moving to Schedule III of the Controlled Substances Act Duane Morris LLP & Affiliates, for instance, provided an explainer that indicates Section 280E provides that: “No deduction or credit shall be allowed for any amount paid or incurred during the taxable year in carrying on any trade or business if such trade or business (or the activities which comprise such trade or business) consists of trafficking in controlled substances (within the meaning of schedule I and II of the Controlled Substances Act) which is prohibited by Federal law or the law of any State in which such trade or business is conducted.” Once cannabis is rescheduled as a Schedule III substance, Section 280E will not apply to that company’s tax return and additionally, the company would no longer be banned from deducting expenses on tax returns like any other type of legal business. Kilpatrick Townsend & Stockton LLP provided a Truth vs. Fiction article that explains  reclassification, in reality, it will probably take over a year for major changes to roll out. But one of the biggest lies or rumors, they explained, is that Schedule III will wipe out existing state cannabis markets. No one knows that at this point, and state cannabis markets have always operated in the gray market.

https://hightimes.com/

New Hampshire Senate Passes Cannabis Legalization Bill

Medical cannabis is legal in New Hampshire, but recreational use has only been decriminalized, not legalized. However, the New Hampshire Senate recently approved of a cannabis legalized bill in a 14-9 vote on May 16, and it’s the farthest that any cannabis legalization bill has reached to date. If passed into law, House Bill 1633-FN-A would legalize adult-use cannabis for those over 21 years of age, and establish a regulatory framework. This includes a possession allowance limit set at four ounces of cannabis, 10 grams of concentrates, and non-concentrate products up to 2,000 mg THC. Currently, the bill allows for 15 adult-use dispensaries to open up throughout the state in order to avoid market oversaturation. On May 16, Senators approved and rejected a variety of amendments. One change prevents cannabis business license owners from using their funds to lobby for cannabis legislation, and also bars those individuals from participating in “political activity” or contributing “funds to any entity engaged” in such activities. Another would present the question “Shall we allow the operation of cannabis establishments within the town or city?” to each municipality. A majority “yes” vote would permit retail outlets to open up, while a majority “no” vote would not permit stores to open, and the question cannot be asked again until three years have passed. Another amendment from Sen. President Jeb Bradley, which he described as his most important amendment, would be to change the proposal of an “advisory board” to that of a “cannabis control commission” in charge of approving rules and regulations. “If we’re going to protect public health, if we’re going to protect the kids in the state of New Hampshire, this board needs to be turned into a control commission,” said Bradley. “Everybody knows I don’t like this bill because of the public health implications. We can make it a little bit better with this amendment.” During the most recent hearing, Sen. Daryl Abbas explained that there is much more work to be done to flesh out the bill as it progresses. “No cannabis policy will be perfect,” said Abbas during the most recent hearing. He added that the current version of the bill “was drafted to balance the public safety needs of our communities with the legalization of cannabis.” Abbas added that previously there had been “some really, really, really scary policies” in the past, referring to one that would have permitted public smoking outside of the New Hampshire State House. New Hampshire polls reflect that a majority of residents approve of legalization. “Most of the polls are pretty straightforward, all well over 70 percent on this,” Abbas said. Sen. Bill Gannon was one legislator who opposed the bill, claiming that it would increase access to drugs throughout the state, making it more accessible to minors, and promote illegal sales. “We are going to change the fabric of New Hampshire if we pass this legislation,” Gannon said. Bradley also expressed his desire for the bill to be rejected by the Senate. “I don’t want to see it get out of the Senate, period,” he told WMUR. However, he admitted that he will do his best to amend the bill should it become law. “If there are 13 votes for it, I’m gonna try to make it the most user-friendly for New Hampshire,” said Bradley. “So keeping the black market out, making sure the regulatory process is tight, making sure that there is a THC limit on the products that can be sold, and making sure that big marijuana—you know, the same as Big Tobacco—is not dominating the politics of the statehouse. To me that’s really important if it’s going to pass.” Despite the opposition, advocates celebrated the news and potential future of cannabis in New Hampshire. Organizations such as Marijuana Policy Project praised the move on social media, but urged New Hampshirites to contact state senators and make their voices heard. Similar reactions were seen when the House approved the bill in April, such as Vicente LLP director of regulatory policy for cannabis and psychedelics, Jen Flanagan. “As with every other state that has legalized cannabis, New Hampshire must work out the details that work for their state and I hope the Senate takes this opportunity to see that safe and legal products are best for the public health and public safety of communities,” Flanagan said. Next up, House Bill 1633-FN-A will be heard in a second Senate committee, and later receive a second Senate floor vote, before it can be sent back to the House with the new amendments.  There is still the obstacle of getting the bill passed by New Hampshire Gov. Chris Sununu as well. Last May, Sununu explained his stance on cannabis legalization. “During my years as Governor, a bill to legalize marijuana in New Hampshire has never garnered enough bipartisan support to reach my desk. I have never vetoed legislation to legalize recreational marijuana,” he said in a press statement. “In 2017, I was proud to be the first Governor in New Hampshire history to sign legislation decriminalizing small amounts of marijuana so that no one would go to jail for simple possession. We expanded access to medical marijuana and provided a pathway to annul old convictions for marijuana possession.” Earlier this month, Sununu reiterated his criteria for signing a cannabis legalization bill. “I laid out the eight or 10 things that I’d like to see in that bill for it to get a signature on my desk,” he said in a WMUR interview. “If they meet those stipulations, I’ll sign it. If they don’t, I won’t.”

https://hightimes.com/

Psychedelics Task Force Bills Signed by Maryland Governor

On May 17, Maryland Gov. Wes Moore signed two bills that will create a psychedelic task force, called the “Task Force on Responsible Use of Natural Psychedelic Substances,” which was established by the passage of House Bill 548 and Senate Bill 1009. Effective starting on July 1, 2024, the two bills green light recruitment for the task force, which will consist of 17 members. Together they will research a variety of considerations for “natural psychedelic substances,” including psilocybin, psilocin, dimethyltryptamine (DMT), and mescaline (but not peyote). The task force’s mission is to recommend law and policy changes in order to build a program that “enables broad, equitable, and affordable access to psychedelic substances.” Task force members will also assess the best research available to better understand public benefits and uses of “natural psychedelic substances,” as well as review potential risks, and examine the best courses of action to increase accessibility.  Additionally, the task force is also required to study various barriers for healthcare practitioners and facilitators, such as insurance, licensing restrictions, zoning, advertising, as well as financial services. Members of the task force will also need to review how to approach civil penalty punishments for “the planting, cultivating, purchasing, transporting, distributing, or possessing of or other engagement with natural psychedelic substances.” The bills also address the requirement of expunging Maryland residents who were convicted of nonviolent psychedelic-related crimes, as well as releasing those serving time in prison for such crimes. The 17-member task force will include the following: a Senator representative, a House representative, the Secretary of Health (or Secretary’s designee), the Secretary of Disabilities (or a designee), the Secretary of Veterans Affairs (or a designee), the Director of the Maryland Cannabis Association (or a designee), a representative from either the University System of Maryland, Johns Hopkins University’s Center for Psychedelic and Consciousness Research, or Sheppard Pratt (a private, nonprofit healthcare provider), a representative from a Native American tribe with experience in religious and/or spiritual use of psychedelics, a behavioral health expert, a substance use disorder expert, a chronic pain treatment expert, a psychedelic-assisted psychotherapy expert, a psychedelic researcher, an expert regarding care in underserved communities, a drug policy reform expert, a law enforcement expert, a patient suffering from conditions in which psychedelics can help treat, and finally a physician who has experience with the “appropriate use” of psychedelic substances. The task force will be required to combine their findings in a report and sent to Moore and the general assembly no later than July 31, 2025. However, the task force will remain operating until December 31, 2026. HB-548 was introduced earlier this year in January, and passed in the House by March 13, with a final passing in the Senate by April 3, while SB-1009 followed suite with an introduction in February, followed by passage in the Senate on March 18 and House passage on April 2. While SB-1009 was still being considered in the Senate, sponsor Sen. Brian Feldman explained that cannabis has received its fair share of studies, and now it’s time to focus on the benefits fo other psychedelics. “This is actually an area that’s been studied far more than cannabis, whether for behavioral health issues related to post traumatic stress disorder, addiction broader behavioral health, depression issues, addiction, chronic pain, just another tool in the toolbox when you’re dealing with a treatments,” Feldman said in March, according to a WYPR news report. University of Baltimore, Maryland pharmaceutical studies professor, Andrew Coop, explained that there are numerous studies being conducted and show a lot of promise with psychedelic-assisted therapies. “There are 54 clinical trials currently going on in Maryland and again, with a safety profile, almost unheard of showing including no overdose, no withdrawal, no hangover and no addiction,” Coop said. “There are clinical trials funded by the National Institutes of Health. The Food and Drug Administration has designated psilocybin a breakthrough therapy. The Department of Defense is funding psychedelic research for veterans. This shows the support of the federal government and the safety profile.” Maryland legalized medical cannabis in 2013, while adult-use cannabis was approved by voters in November 2022, and sales began in summer 2023. Approximately 100 medical cannabis dispensaries were permitted to sell adult-use cannabis products at launch, and during the first week of recreational sales the state collected $20 million. The mainstream status of cannabis continues to grow, and it’s affecting more than just consumers. Maryland Law Enforcement officer applicants are currently required to abstain from cannabis use for three years before being considered, but in January Montgomery County Police Chief Marcus Jones stood up against that rule. “I think in today’s environment, where we are with the legalization of cannabis, that has now restricted law enforcement agencies, particularly larger agencies, across the state,” said Jones.In the meantime, Marylanders are already learning about the benefits of psychedelic-assisted therapy firsthand. Businesses such as Inner Path Wellness, based in Baltimore, Maryland, are offering an outlet to experiment with psychedelics as a treatment. Patient Tim Hamilton provided an oral testimony to the General Assembly on March 14 about the efficacy of such treatments. “They saved my life and it’s made me a better husband, a better father, and a better person,” Hamilton said. “It can help millions of people.”

https://hightimes.com/

The Real Sticky Icky Icky

Willie Nelson. Cypress Hill. Bob Marley. Aside from them, not many artists are more synonymous with cannabis than Snoop Dogg. Following his appearance on Dr. Dre’s 1992 single “Deep Cover,” the D-O-Double-G played a starring role on Dre’s debut solo album, The Chronic, which (in addition to the title itself) put their affinity for the sticky icky icky front and center. Not only was it marketed as a pack of rolling papers, it also contained track titles such as “The $20 Sack Pyramid” and “The Roach (The Chronic Outro).” Over the years, his connection to cannabis grew even stronger and in 1999, he and Dr. Dre teamed up again for 2001, the six-time platinum follow-up to The Chronic. With a green marijuana leaf tucked neatly into the right corner of the album cover, the weed theme continued with songs like “Let’s Get High” and Nate Dogg’s unforgettable hook, “Smoke weed every day-e-ay.” Snoop momentarily quit smoking once in 2002 and then again in 2005 when he started coaching a youth football league, but his hiatus didn’t last long. After about three months, he was ready to light up again. He’s been certified for medical cannabis in California to treat migraines since at least 2003, and in 2013, he claimed to be smoking approximately 80 blunts a day. Now, more than 10 years later, Snoop Dogg is intertwined with cannabis culture. Snoop’s loyalty to herb was tested in November 2023 when he tweeted out of nowhere, “After much consideration and a conversation with my family, I’ve decided to give up smoke. Please respect my privacy at this time.” People clutched their proverbial pearls in shock. Did hell freeze over? Is this a sick joke? Is Snoop OK? But, as many suspected, it was all a marketing ploy, and turned out to be a sales gimmick for a smokeless fire pit. After all, Snoop has become omnipresent in the world of advertising, endorsing everything from Corona beer and Tostitos to The General Insurance and Dunkin’ Donuts. His latest endeavor is a hemp-infused beverage called Do It Fluid, billed as an alternative to traditional smoking through “all-natural, high-quality ingredients that don’t sacrifice the high.” The line, created by the Hill Beverage Co., features THC and CBD infusions through four flavors in CBD-only and CBD and THC blends. “I’ve been in the cannabis game for decades, and I’m always looking out for revolutionary products,” Snoop Dogg says. “I love seeing new technologies and trends and being a driver of those. I always make time for things I’m passionate about, and two of those things happen to be weed and innovations.” For the uninitiated, Snoop Dogg began his career at Death Row Records and, in a full-circle moment, acquired the brand in 2022. Part of the restructuring included a new arm called Death Row Records Cannabis, which is ultimately how Snoop and Hill Beverage Co. formed a partnership. “My partner and head of operations, AK at Death Row Records Cannabis, connected me with Jake Hill and we started ideating flavors and ideas for a hemp-infused drink,” Snoop explains. “Beverages are ingrained into us humans as a familiar format of consumption, and I wanted to make sure as many people had access to Do It Fluid as possible, which is why we chose the hemp-derived delta-9 THC and CBD route.” To create the flavors, Snoop joined with Tiffany Chin, his head of cannabis and hemp operations, to come up with fruit punch and blue razz. “Jake’s team developed an amazing blood orange flavor that tied perfectly into the Death Row Records history,” Snoop says, alluding to former Death Row Records CEO Suge Knight’s association with the Piru Bloods gang. “Do It Fluid is just the start in my partnership with Hill Beverage Co. We’re looking to create more flavors, collaborations and product lines in the future to get to my fans and consumers, those who do and don’t know cannabis.” And Snoop knows cannabis. In 2015, he founded his own marijuana brand, Leafs By Snoop, but eventually shelved that brand for Death Row Cannabis, which became available in California last year and has since expanded to Michigan, with several more locations planned. AK, a longtime West Coast legacy cultivator, evidently has a flair for engineering tasty buds. But, of course, it’s much more than just business for Snoop—he’s a dedicated connoisseur. “I love the way it makes me feel and gets my creative juices flowing and how it bonds people in the creative world,” Snoop says of cannabis. “A lot of people enjoy smoking to listen to music and watch TV and movies. It just elevates the mind to a different place.” Right on cue, Snoop Dogg plugged his brand the moment he got the opportunity. When asked what a day in the life is like for him when it comes to smoking, he replied, “I wake in the morning, grab my Death Row Records Cannabis jar, unwrap a blunt, shake the guts out, and break the bud down with my fingers. After I smoke my blunt, I have another one ready for after my meetings and/or during rehearsals and recording. Death Row Records Cannabis has me stocked up on the best bud in California. It’s the only weed I smoke.” As Snoop Dogg’s business portfolio continues to expand, the 52-year-old has plans for incorporating a little self-care, too. “I have so many projects on deck and new products flooding all lanes and bringing more and more to my fans,” he says. “On a personal level, I’m also working on leading a healthier lifestyle, drinking more water, getting in the workout and eating better, eating right. 2024 is looking fantastic.” This article was originally published in the May 2024 issue of High Times Magazine.

https://hightimes.com/

The Library of Cannabis

Up in California’s Emerald Triangle, just north of Cal Poly Humboldt and nestled between the Mad River and a community forest, HendRx Farm is a commercial nursery dedicated to cataloging the community’s work with the cannabis plant. What started as a simple 400-square-foot operation now spans almost 10,000 square feet across multiple locations, keeping around 200 varieties of clones at a time in their catalog and serving farms across California. Together, Daniel Hendricks, Jeff Schirmann, and David Lunsford have built a resource where the preservation of plants is paramount. The calling at HendRx Farm is to create a viable source for farmers to secure not only the clones that are high value right now, but also the ones that helped put this whole game together, strains like Ringo’s Gift, Arcata Trainwreck, or Skunk #1. HendRx believes the mission to procure and hang onto these culturally-significant cultivars is not just a community service but a responsibility. Every sprout has a story to tell, and HendRx is helping to assemble the Criterion collection. I spoke with Hendricks while he was getting started on the clone selections for the next few growing cycles. “With an operation like this, juggling orders for so many farmers, you have to be seasonally minded,” he said. The company started in 2014, but for Hendricks, his days of growing can be traced back to the ’90s. Having grown up in Humboldt, he was attracted to cultivation and breeding early on, eventually finding companions who shared his enthusiasm for weed. Hendricks, Schirmann, and Lunsford bonded over the belief that a person has a right to farm, as well as a mutual thirst to learn the history of the cannabis strains that had proliferated throughout the West Coast. Together, the group became known for helping authenticate strains for growers. “We were good at validating if something was the real version of what you were after,” Hendricks said. In 2016, they chose to file as an official nursery after deciding it was not only what matched their shared passion but also what they felt the legal cannabis community needed most. Hendricks chuckled while describing their first setup. “It was this tiny little square box that was barely big enough for all of us and the plants,” he said. Today, they’ve developed that passion into a large-scale, thriving business that includes the launch of their genetic preservation library, where they authenticate, stabilize, and store cultivars that the community has deemed essential. Half of their main building is dedicated to this breeding project. The goal is to get up to 80 strains in the library, all independently bred, stabilized, and preserved through clones. Attaining this goal, Hendricks said, is in no small part thanks to their partner farms like SoHum Seeds and Hidden Prairie Farms, which grow these strains out and help them develop phenotypes for possible production. “We rely on them for so much, in terms of testing the product by growing and smoking it, but hearing their stories about how it grew, seeing all the effort and coordination from around the community, that’s undoubtedly the most fun part,” he said. It’s that feeling of community responsibility and respect that put HendRx in the unique position to preserve and become stewards of the famous CBD strain, Ringo’s Gift. Hendricks spoke about how this incredible story shows how the breeding and nursery community can work together to make sure something doesn’t disappear once the spotlight fades away. After cannabis breeder Lawrence Ringo’s passing in 2014, Hendricks was at a memorial service in Mendocino, where he heard Samantha Miller from Pure Analytics Lab talk about the first time they discovered the presence of CBD in Ringo’s Gift. She described how everyone on the call afterward was cheering and laughing and how inspired everyone felt. The HendRx team knew they had to hunt and find the seeds so they could, in some small way, do their part to honor this work. They worked tirelessly to find two variations of Ringo’s Gift, eventually called Katie’s Cut and Levi’s Cut. After a lot of calls and messages, they managed to procure a hemp-compliant clone hunted to help treat the mother of a local client named Katie. Then, with the aid of Purple Caper Seeds (creators of the Chocolate Hashberry), the HendRx team was able to get their hands on a cut that had been given to Purple Caper by Ringo’s son, Levi Lawrence, in a parking lot in San Jose, California years prior. This cut, now known as “Levi’s Cut,” was another key part of HendRx’s efforts. Armed with two versions of the plant, they went to work. Hendricks started making 1:1 hybrids while Schirmann began to stabilize it with a hemp variety, and then the calls started flooding in. People had heard about what they were doing and wanted to get their hands on this important medicinal strain to give to their friends. Among these calls were Levi and Danielle Lawrence, who then operated SoHum Seeds. After giving this strain back to Ringo’s family, to the very person who had handed over this cut in a parking lot years earlier, HendRx felt they had really achieved something important for the nursery community. Levi and Danielle Lawrence eventually chose Jerry Savage to operate SoHum Seeds to continue the Ringo’s Gift legacy, and Savage invited HendRx to be part of that mission. Today, HendRx manages facilities at SoHum Seeds in Whitethorn, California, where they operate an R&D section, along with garden space for Savage Farms. After successfully working with the Ringo’s Gift through breeding and experimentation, Hendricks figures they’ve successfully created at least 50,000 Ringo’s Gift plants over the last two years. “It’s definitely the most important clone we have, and it’s at the ethos of what HendRx does: preservation,” he said. When it comes to the concept of cannabis and legacy, Hendricks said that they prefer to use the term “heirloom” when referring to their work since it “better holds the reflection of what these strains are: plants with a rich position in history and a huge potential value to the future.” For them, these plants haven’t yet finished writing the legacy they will leave behind. Part of their daily mission is ensuring these heroic varieties make it to the final battle. To Hendricks, “legacy strains,” as the term pertains to retail cannabis, are too expensive to keep alive in today’s market, given the current profit margins. This makes preserving genetics paramount to ensuring we don’t lose what we already have, as people today are planting less of the classics like San Fernando Valley OG and newer strains like Lemon Cherry Gelato. “Preserving these strains ensures these plants don’t just leave behind a legacy, either because they stay valuable to the community or to the retail market,” Hendricks said. “It’s our duty to the community to preserve what the industry won’t save.” The Oxford English Dictionary definition of heirloom, in reference to plants, refers to a variety that is not associated with large-scale commercial agriculture. Hendricks referenced how the inherent value in these strains isn’t just in their flavor, historical importance, or medicinal value but also in the untapped intellectual property value the industry has left on the table. If a brand figures out how to adapt an heirloom strain for scalable cultivation and makes it a flagship product, especially one that’s part of their company mission to give back to cannabis, then that in and of itself is a valuable brand identity that’s empowered by that cultivar. In a way, that’s part of the work HendRx is doing, along with The Humboldt Legacy Project on the famous cannabis strain Skunk #1. After being procured by David Watson and preserved by Marty Yip of Sensational Solutions, HendRx was entrusted with the Skunk #1 to work with. Together with the Humboldt Legacy Project, they’ve already started testing something they’re calling the HLP Skunk #1 No. 1 or HLPS1. Currently, HendRx is in the second round of tester gardens grown through their partners in the project, MOCA Humboldt, which took home nine awards for their cannabis at the 2023 California State Fair. Hendricks remarked how together they are isolating possible production candidates like this HLP Skunk #1 No.1 but explained that the process is still a while away from a batch of clones being considered for retail because “some of these [plants] need commercial work and are perhaps unattainable under our current framework.” He went on to explain how the time and supplies required to grow a difficult heirloom strain, or something that takes 14 weeks or longer to finish up, often outweighs the possible return on investment, making them a harder sell during planting season. “Things like this require a big price tag in order to break even,” Hendricks said. “Growing a field of something like Trainwreck really needs subsidized farming.” Despite these concerns over sustainability in the current retail market, they were able to release a small amount from the first test garden to the public, including a survey created by HLP and HendRx that asks smokers for their feedback. Hendricks says the staff at MOCA Humboldt are all hyped about having this opportunity and someday being able to offer a product with an unbelievable history and proven provenance for smokers who want to try that old-school ’90s weed.  What does it take for a strain to end up in HendRx’s genetic preservation library? The answer to that is both simple and complex. “It has to pass the three wise men,” Hendricks said, meaning all three owners of the nursery have to look at each case and approve it, but there are a few factors that majorly contribute to the decision. Cost is an important factor. It takes around $1,200 a year to keep a single strain stored away. Hendricks admits that switching to tissue culture would be a smaller footprint for storing their library, but it would keep things further out of commercial rotation and increase wait times for their farm partners. Another big criteria is space, not just in terms of where to store plants but also how to store multiple cultivars together so that there’s a healthy ecosystem. Inside their Noah’s Ark, everything is operating in a sort of hibernation homeostasis, and there’s always a potential risk involved in bringing them out and back into storage. If a strain can prove itself to have a valuable history, be free of pathogens, and can do well in its storage facility and pass the test for all three owners, then it becomes part of the genetic preservation library. Hendricks made it clear that the library is about preserving older strains but that recent and current ones aren’t excluded from induction. “It has to be important, not just cool, and it has to have potential value in terms of research, rarity, terpene breakdown, market value, or education,” he said. He sees the mission as keeping these cultivars alive for the future, even more so than in the past. They recognize that the new heat and throwback strains from the ’90s might be more in demand than the hits of the ’70s, but that doesn’t mean those flavors don’t contain something super inspiring for the future. The whole thing is a lot like the preservation of music. There are more albums made in a day than you could listen to in a year, so deciding who and what gets preserved is a difficult task that requires a lot of dedication, research, and input from the community, along with a little bit of intuition sharpened by experience. One example he gave is Italian Icee, a strain that has gotten them a ton of positive feedback and is something they had a gut feeling about when it first landed in their hands. Hendricks explained that it was a rugged, sunbaked German man who approached them. He looked like a guitar tech or a roadie for some band your uncle loves and he said he had something special they needed to keep safe. He came back the next day with a tiny piece of paper that held a pile of seeds and the instructions for his Mason jar technique for germination; all hastily scrawled out like the recipe for a wizard’s potion. It was a gut feeling the guys at HendRx had that led them to keep it. After all, Ice Cream Cake crossed with Blueberry Muffin is nothing to necessarily write home about, but HendRx had a hunch, so they had Royal Lief grow it out and select the pheno: Ice Cream Cake x Blueberry Muffin #4. After that, it traveled to the R&D site at SoHum Seeds, where it languished for a year and a half before a client came asking for an Ice Cream Cake cross. Now, six years after getting that crumbled scrap of paper, Italian Icee has done quite well, a success Hendricks modestly attributes to the strain finding the right home for its story rather than the HendRx team’s gut instinct for sniffing out a winner. For every success story like this, there are a dozen or more heirloom cultivars waiting to find their voice in this evolving industry. I asked if any of these were becoming in demand with farmers last year in 2023, and Hendricks said that HendRx is getting a lot more requests from people wanting to try their hand at growing an heirloom strain, but producing orders on these cultivars takes a lot of time and labor so there are waitlists for many of the most recognizable names. “The longest lines are always for Trainwreck, Sour D, and Tangie,” Hendricks said. “But the lines for NF1, XJ13, and GSC are right at their heels.” Hendricks said his company likes to say the mission ends when you can find Sour D and Girl Scout Cookies in the garden department next to tomato starts and daffodils. The idea is that when they can create and maintain these strains for home gardeners and commercial growers alike, they no longer have to worry about these strains leaving enough of a legacy to be saved from extinction. Until then, HendRx will continue to expand the genetic preservation library to conserve and promote heirloom cannabis. This article was originally published in the May 2024 issue of High Times Magazine.

https://hightimes.com/

The Weirdos State of the Union

Another year being weird is in the books, and what an eventful one it’s been! From THCa to Schedule III, our community is jumping through as many loopholes as ever, and with just as many doomsayers out there waiting to yuck our yum. It can be both exhausting and exhilarating at the same damn time. As usual though, while the doom & gloom may be great for headlines & clicks, the hearts of the diehards beat on. Our demise is continuously overstated – we’re a resilient kind. We continue to find a way. Over the past year we’ve covered some major ground in our little experiment over here – from fighting bullshit legislation, to sounding the alarm about spray terps, rebranding the term stoner to praising mylar bags – it’s hard to think of any hot button issues we DIDN’T bitch about. We campaigned for small batch, and macrodosing, while asking important questions like ‘can weed bring us closer to god?’ and ‘who raised you fucking people?’. I called many of us addicts, while Matt called those who don’t smoke cops. (Only teasing, he didn’t say that.) But to say we’ve got range, and depth, at this point I’d say that’s a pretty massive understatement. We’re fuckin’ meta, baby. (The adjective, not the company.) It’s crazy to see the legs this lil’ section has developed, and the voices that are now asking to be a part of it – we’re truly just getting started… But if you remember last year’s recap, I had promised to evolve this section with some new features & assets that I thought would be coming online and well… they didn’t. Instead, some other things happened, and we’ve had to take a different direction, so let’s start there. Now if you’ve been following the news lately you might’ve seen some stories out there starting to count us out, or preying on our demise. I’ve had a lot of articles shared with me over the past few weeks that contained questionable information about the company and our situation, so I figured this was a good medium to set the record straight. I know every person that dislikes the brand or me personally has shared these articles, and celebrated that we’re likely all out of jobs. Well friends, I hate to break it to you, but the truth, as always, is likely going to be much less satisfying than the idea you’ve made up in your head. You’ve got some valid questions and while I don’t have all the answers right now, I’d like to give a little update for all of you wondering what’s up. Right now, High Times is in the process of a rebirth. While I can’t speak to or for any other area of the High Times enterprise, I can speak to what’s going on in this particular house. As you all know, our media business is an important cornerstone of this industry. Now in its 50th year of operation, the magazine’s voice has been a rallying cry for our culture longer than most of us have been alive, and it’s one many people, including myself, would like to see given the proper love and care it deserves in order for it to continue to bear fruit for the community for many years to come. Because of that, and many other things that actually have very little to do with us, High Times is currently in the process of changing ownership. Similar to the acquisition that happened in 2017, sometime in the next few weeks, or months, High Times will be acquired, and thus have a new owner. We are in a process right now where court appointed representatives are studying what we do & packaging up our business to offer it to potentially interested parties who may want to develop or operate it going forward. This is company-wide, and every asset and business area we have is being analyzed.  Now, our media business has operated independently from the other business areas forever, but it is possible, and honestly likely, that this side of High Times will be separated from some of the other assets our former leadership amassed over the past few years. I know that this may seem like a loss for the brand, but in reality optimizing our lean business model in order to ensure we can grow and prosper for years to come is essential for every business, and it’s the media side’s biggest priority. This is likely a necessary decision for the future of all of our current business areas. Speaking for my team, we all love what we do, and are honored to do it – we simply can not imagine letting this voice fall off into the ether, and we’re doing everything in our power to protect it. While it’s not 100% in our control, I’m feeling pretty good about the future right now, for the first time in a while. While sure, any change of this magnitude is scary, and uncertain, the truth is that High Times is an incredibly resilient brand. It WANTS to breathe, and grow – it just needs the room to do so. Had you told me 10 years ago High Times would be publishing longer than VICE I probably wouldn’t have believed you, but with all I’ve seen over the past 7 years here it no longer surprises me. I have watched countless people try to hold us down or count us out in my time here, and none have been successful. The brand continually carries on in spite of whatever gets in its way. High Times really is just like the plant we all love so much, it’s a weed – it’ll bloom through whatever cracks of light it gets. And we’re here to prod those little cracks to let some more light in. Now, while I can’t promise that whoever the new owner is will want to keep me or any of this around, I can tell you my priority is ensuring this team continues on. That the work continues on. What I can promise you, dear reader, is that I will keep doing whatever in my power is best for this business, this brand, this community, and the information that you deserve, no matter what the future brings, or what may happen to my role at this company. I have fought many an executive who thought we could just Chat GPT this work out, and I am not afraid to continue that argument as long as they’ll have me, but we don’t get to control everything… Whatever the case, we’ll find a way forward. So with that brief explainer, let’s loop back around to my initial point.  Because of all that’s been going on the past few months, the growth that I expected to see at the end of last year obviously hasn’t happened – respectfully, our priorities have to shift with the business – but rest assured, we haven’t given up! In fact, in true High Times fashion, we turned those lemons to lemonade, and worked out some new, more cost-effective, ways to get these ideas over the finish line. We even worked out a few kinks to spruce the projects up a bit. While we’re still underwater dealing with this sale, and addressing the very real concerns many of you have raised to us, I am confident that the new model we’ve hypothesized will allow us to create a bunch of that content we’ve been waiting to make for you – no matter who is manning the ship at that point. I don’t want to let too much out of the bag yet, but yes, we have heard all your requests for video content and podcasts, and we’re not too far from the day we’ll get to introduce them to you. I know you’ve got more questions – and that the road ahead seems long, and tired, but the truth is we’re far closer to many of our goals than we’ve ever been, and we’re all fighting harder than ever. With all the momentum we’ve built over our collective history in this fight, let’s not forget to remember how far we’ve come. We’re doing the things our ancestors thought impossible; it would be silly to give up now. 

https://hightimes.com/

Gifting Parties in Connecticut Can Continue with Limits Under Settlement with Attorney General

Gifting parties—events that allow guests to buy a random item that includes a cannabis “gift”—will be subject to strict rules after Connecticut’s attorney general arrived at an agreement with organizers of one such event that attracted attention of state officials. Attorney General William Tong announced May 15 that he reached an agreement, with stipulations, that HighBazaar organizers Joseph Accettullo and Cody Roberts can continue running gifting parties, however, the parties will not resemble what they used to be. For $20 per ticket, attendees could gain entry to the event to buy accessories or other items and receive cannabis “gifts” on the side in an attempt to cut corners—namely, avoiding the law requiring sellers to have a license. Connecticut banned cannabis gifting events in 2022. Tong alleged that HighBazaar events were essentially cannabis marketplaces that subverted Connecticut’s legal, regulated cannabis market. HighBazaar’s gifting events were canceled last January after Tong issued cease-and-desist orders in a letter to organizers and the venue.   “It appears that these events involve the illegal marketing and sale of cannabis outside of the regulated market and that the events are accessible to individuals under the age of 21,” the letter read. Tong warned that the markets appeared to violate the Connecticut Unfair Trade Practices Act (“CUTPA”), General Statutes § 42-110a, et seq., the Responsible and Equitable Regulation of Adult-Use Cannabis Act, General Statutes § 21a-420, and/or other applicable laws and regulations. But Tong reached an agreement with HighBazaar that will allow them to continue to operate with several restrictions. “HighBazaar operated unlawful cannabis markets where vendors peddled untested, illegal products. Not anymore. This stipulated judgment forces a series of strong, ongoing obligations, including clear and conspicuous disclosures and acknowledgements that the sale, distribution and exchange of cannabis will be strictly prohibited at any HighBazaar event. We will be watching closely—including unannounced inspections—to ensure strict, ongoing compliance,” said Attorney General William Tong. The stipulations include that Accettullo and Roberts must make clear and conspicuous disclosures at HighBazaar events and on any advertisements that the sale, distribution, or exchange of cannabis will be strictly prohibited.  All prospective vendors must be notified in advance, and must acknowledge in writing that they will not sell, offer, distribute, or exchange cannabis at any HighBazaar event. judgment provides the Office of the Attorney General the right to enter and inspect HighBazaar premises at any time to ensure compliance with the agreement. CT Insider reports that Alex Taubes, an attorney for HighBazaar organizers, called the judgment a “great victory” and said he was “pleased that the state finally saw some reason.” The Office of the Attorney General also previously sent notice to EventBrite, where HighBazaar was promoting its gifting events. The letter warned that such posts violate EventBrite’s own Community Guidelines and that the events they promoted also violate Connecticut law. The Office of the Attorney General has an active and ongoing investigation into EventBrite’s continued marketing of unlicensed cannabis markets in Connecticut. Assistant Attorneys General Jonathan Blake and Addison Keilty, and Deputy Associate Attorney General Michael Wertheimer, Chief of the Consumer Protection Section, assisted the Attorney General in this matter. Another legal loophole in Connecticut led to THC-infused seltzers surging in popularity. Liquor stores in Connecticut are selling THC-infused drinks such as seltzers legally, due to a legal loophole regarding dosages listed on the cans. Cannabis retail stores are selling cans listed as one serving, but the same cans of cannabis-infused seltzer, usually running in sizes from 7.5 – 12 ounces, are labeled as five servings in a package at a liquor store or market. All they have to do is ensure that each serving contains less than 1 mg of THC per serving and they can sell the seltzers without violating state law. CT Insider reports that when the drinks are labeled as five servings rather than one, they are technically legal to be sold anywhere in the state, so long as other elements of the packaging are in line with state rules. Connecticut’s Department of Consumer Protection (DCP) clarified that the drinks are indeed legal. “A package containing less than 1 milligram of THC per serving and less than 5 milligram per package is not considered cannabis, and may be produced and sold without a license,” DCP spokesperson Kaitlyn Krasselt confirmed.  Connecticut legalized adult-use cannabis in 2021 and later became available for purchase by adults at retail outlets in January 2023. Connecticut Gov. Ned Lamont signed legislation to legalize adult-use cannabis in June 2021, ending the prohibition on possession of cannabis by adults 21 and older and creating a framework for regulated adult-use cannabis sales. Connecticut’s cannabis market showed steady growth

https://hightimes.com/

Twenty-One of 27 European Union Countries Legalized Medical Cannabis, Report Highlights

Medical cannabis is taking over Europe, as well as efforts to decriminalize cannabis in numerous countries and at local levels. In a pattern similar to what took place in the U.S., European nations are legalizing cannabis for medical or recreational purposes in a patchwork of new laws. According to a May 16 press release from Victoria, Australia-based Biortica Agrimed, 21 out of 27 member states of the European Union (EU) legalized medical cannabis. “The EU situation with respect to legalisation can best be described as fluid, but evolving positively,“ said Tom Varga, CEO of Biortica Agrimed. Biortica Agrimed is a vertically-integrated B2B company  preparing to list on the Australian Securities Exchange with an IPO. The 27 EU countries are Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden. Out of those, 21 countries—Austria, Belgium, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovenia, and Spain—implemented laws to allow for the medical use of cannabis. Out of those countries, the potential market in Germany is among the most exciting and where investors are circling the most at the current moment. “Whilst EU law prohibits the commercial sale of cannabis, many countries are taking a more mature approach, and legalising, initially medicinal, and ultimately personal use, with Germany in the lead. 21 out of the 27 EU member states have legalised use of medicinal cannabis,” he said, “and 13 countries have either legalised or decriminalised its personal use.” Countries like Spain have decriminalized cannabis, while Georgia, Germany, Luxembourg, and Malta have taken steps to legalize adult-use. Countries like Portugal have gone even further by decriminalizing all drugs. Dozens more cities in the EU decriminalized cannabis at the city level. Part of the purpose of Biortica Agrimed’s report is to support the argument that it’s due time Australia takes note of the potential Down Under. Australia legalized medical marijuana in 2016. According to Therapeutic Goods Administration (TGA) data, the number of patient approvals for medical cannabis increased sharply. In Australia, doctors can prescribe medicinal cannabis with the approval from the TGA and the relevant State or Territory’s Health Department. “The EU comprises world class nations, and Australia should take any learnings that we can from the EU.” he said, “We have the benefit, and indeed the privilege, to view how legislative frameworks have been built over-seas, what’s worked and working, and what the Australian industry and legislators should avoid. Australia really can do better.” “We look forward to continuing to share our global industry research with the Australian industry, our legislators and regulators, to build an industry that we can all be proud of, an industry that puts patient care, safety and outcomes to the fore, ” said Varga. Cannabis remains the most popular substance used in Europe according to the most recent counts by European data monitors. The European Monitoring Centre for Drugs and Drug Addiction’s (EMCDDA) report, entitled “Cannabis—the current situation in Europe (European Drug Report 2023),” describes cannabis as “by far the most commonly consumed illicit drug in Europe.” The report cites national surveys which show that 8% of European adults (out of approximately 22.6 million people between 15 and 64 years of age) have used cannabis within the last year. An estimated 1.3% of adults (approximately 3.7 million people) are described as “daily” or “almost daily” consumers. With the popularity of cannabis continuing to grow, the report notes that this often leads to consumer “problems.” “There remains, however, a need to understand better the kinds of problems experienced by cannabis users, as well as the referral pathways and treatment options available for those with cannabis-related problems,” the report stated. Germany’s legislation to legalize cannabis took effect on April 1. German lawmakers gave final approval to a recreational weed legalization plan known as CanG recently, making the country the largest in Europe to take the step. In the German capital of Berlin, cannabis smokers gathered at the iconic Brandenberg Gate to smoke weed and celebrate their new freedoms. Other events were held throughout Europe’s most populous country, including one in front of the Cologne cathedral and others in the cities of Hamburg, Regensburg, and Dortmund. The patchwork of laws unfolding in the EU show how medical and adult-use cannabis are popular on a global scale, and what Australia could learn from European countries.

https://hightimes.com/

New Study Analyzes the Effects of THCV, CBD on Weight Loss

New research, which was published in the journal Cannabis, shows evidence of the weight loss effects of cannabinoids such as THCV and CBD. The study’s official title is “Weight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips,” and studied participants’ use of oral strips to administer a combination of THCV/CBD or a placebo. The study specifically analyzed metabolic syndrome, which develops when an individual accumulates fat, and causes the body to experience “inflammatory response, insulin resistance, dyslipidemia, hypertension, and fatty liver disease.” The condition can be caused by a variety of factors, most commonly due to chronic inflammation caused by fat deposits or eating too many calories and not exercising enough. Ultimately, metabolic syndrome can lead to more serious conditions such as diabetes, and an increased risk of a stroke or heart attack. The human body’s endocannabinoid system has previously been confirmed to have positive effects on energy homeostasis (the regulation of energy in the body) and appetite regulation, and researchers set out to analyze how the phytocannabinoids THCV and CBD affect metabolic syndrome. According to the World Health Organization data from 2022, an estimated 2.5 billion people adults over 18 were considered to be overweight, while 890 million were living with obesity. Older data from the U.S. Centers for Disease Control and Prevention collected between 2017-March 2020 shows that in the United States, 41.9% of adults older than 20 are obese. This most recent study utilized 31 female and 13 male participants, all with an average age of 51.75 years. Participants were given one of two different doses of THCV/CBD, or a placebo. The lower dose included 8 mg THCV/10 mg CBD, while the higher dose included 16 mg THCV/20 mg CBD, which was taken daily via mucoadhesive oral strips over the course of 90 days. Researchers shared that there were significant results to report. “Use of the THCV/CBD strip was associated with statistically significant weight loss, decreases in abdominal girth, systolic blood pressure, and total and LDL cholesterol,” researchers explained. “The study was limited by small sample sizes in both the high dose and placebo groups.” Ultimately, participants who were given both the lower and higher doses of THCV/CBD showed the most improvement. “The 16 mg/20 mg daily dose was superior for weight loss compared to the 8 mg/10 mg daily dose; both sets of results differed from placebo in a way that was statistically significant. The results of this study were congruent with the prior unpublished studies of a hemp extract containing significant percentages of THCV, CBDV, and CBD,” researchers concluded. THCV is said to have been first discovered by researcher Edward Gill and his team in 1970. At the time, cannabis tinctures were a licensed medicine in the United Kingdom, referred to in the British Pharmaceutical Codex (BPC). Cannabis tinctures were removed from the BPC of 1932, although it remained in the BPC of 1949. One year after Gill discovered the compound, it was studied by Frans Merkus who officially referred to it as THCV. Although THCV appeared in numerous animal studies over the years, its effects on obesity and its “weight loss” properties came from a study by GW Pharmaceuticals in 2013. Researchers administered various levels of THCV to mice for 30 or 45 days, and then measured food and water intake, weight gain, energy expenditure, and more.  The results didn’t show significant food intake or weight gain, but researchers did note increased energy expenditure. “THCV is a new potential treatment against obesity-associated glucose intolerance with pharmacology different from that of CB1 inverse agonists/antagonists,” researchers concluded. Additionally, another GW Pharmaceutical study in 2016 showed evidence of THCV decreasing “resting state functional connectivity” and increasing “connectivity in the cognitive control network,” leading researchers to suggest positive effects of THCV for obesity. Other studies, such as one published in 2020, also found that THCV could be a beneficial treatment for those with obesity and diabetes. “However, the uniquely diverse properties of THCV provide neuroprotection, appetite suppression, glycemic control, and reduced side effects, etc.; therefore, making it a potential priority candidate for the development of clinically useful therapies in the future. Hopefully, THCV could provide an optional platform for the treatment of life-threatening diseases.” Other studies have shown how THCV can benefit those suffering from Parkinson’s disease, schizophrenia, cancer, pain, inflammation, and untreatable epilepsy. Most recently in February, cannabis genetics company Phylos announced the results of its THCV study using its “Natural Natural™ THCV” product. Phylos Chief Scientific Officer Alisha Holloway, PhD, explained the significance of their findings in a press release. “This study signifies a pivotal moment for the cannabis industry in understanding the effect of THCV in combination with THC,” Holloway said. “The Natural Natural THCV study allows us to leverage our exceptional plants in the advancement of targeted cannabis products, and to chart new territories in understanding the efficacy of natural cannabinoids.”

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.